Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2023   8,311,237    
Beginning balance at Dec. 31, 2023 $ 15,273 $ 1 $ 318,600 $ (303,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (in shares)   344,885    
Stock-based compensation 4,129   4,129  
Net loss $ (119,902)     (119,902)
Ending balance (in shares) at Dec. 31, 2024 8,656,122 8,656,122    
Ending balance at Dec. 31, 2024 $ (100,500) $ 1 322,729 (423,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for PIPE Investment, net of issuance costs (in shares)   1,771,586    
Issuance of common stock for PIPE Investment, net of issuance costs 3,477   3,477  
Deemed dividend to Series A Preferred Stock (403)   (403)  
Conversion of Series A Preferred Stock to common stock (in shares)   10,728,414    
Conversion of Series A Preferred Stock to common stock 21,408 $ 1 21,407  
Vesting of restricted stock units, net and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (in shares)   1,067,678    
Vesting of restricted stock units, net and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (1,382)   (1,382)  
Stock-based compensation 5,543   5,543  
Net loss $ (94,379)     (94,379)
Ending balance (in shares) at Dec. 31, 2025 22,223,800 22,223,800    
Ending balance at Dec. 31, 2025 $ (166,236) $ 2 $ 351,371 $ (517,609)